Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

08/11/2019 08:00

Nov 8 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            104 mln             24 mln                     
                (+327.5 pct)         (-87.9 pct)                  
  Operating       loss 1.22           loss 1.73                   
  Recurring       loss 1.22           loss 1.73                   
  Net             loss 1.26           loss 1.54                   
  EPS           loss 8.01 yen      loss 10.49 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T